Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FDA extends Pulzium PDUFA date

Solvay (Euronext:SOLB) said FDA pushed back the PDUFA date

Read the full 94 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE